313 related articles for article (PubMed ID: 32778004)
1. Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials.
Guillo L; D'Amico F; Serrero M; Angioi K; Loeuille D; Costanzo A; Danese S; Peyrin-Biroulet L
United European Gastroenterol J; 2020 Nov; 8(9):1013-1030. PubMed ID: 32778004
[TBL] [Abstract][Full Text] [Related]
2. [Extraintestinal manifestations of inflammatory bowel disease].
Rogler G; Schölmerich J
Med Klin (Munich); 2004 Mar; 99(3):123-30. PubMed ID: 15024484
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
Khrom M; Long M; Dube S; Robbins L; Botwin GJ; Yang S; Mengesha E; Li D; Naito T; Bonthala NN; Ha C; Melmed G; Rabizadeh S; Syal G; Vasiliauskas E; Ziring D; Brant SR; Cho J; Duerr RH; Rioux J; Schumm P; Silverberg M; Ananthakrishnan AN; Faubion WA; Jabri B; Lira SA; Newberry RD; Sandler RS; Xavier RJ; Kugathasan S; Hercules D; Targan SR; Sartor RB; Haritunians T; McGovern DPB
Gastroenterology; 2024 Jul; 167(2):315-332. PubMed ID: 38490347
[TBL] [Abstract][Full Text] [Related]
4. [Extraintestinal manifestations in ulcerative colitis].
Reinshagen M; Fölsch UR
Z Gastroenterol; 2004 Sep; 42(9):1024-8. PubMed ID: 15455279
[No Abstract] [Full Text] [Related]
5. Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment.
Greuter T; Bertoldo F; Rechner R; Straumann A; Biedermann L; Zeitz J; Misselwitz B; Scharl M; Rogler G; Safroneeva E; Ali RAR; Braegger C; Heyland K; Mueller P; Nydegger A; Petit LM; Schibli S; Furlano RI; Spalinger J; Schäppi M; Zamora S; Froehlich F; Herzog D; Schoepfer AM; Vavricka SR;
J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):200-206. PubMed ID: 27801751
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
[TBL] [Abstract][Full Text] [Related]
8. Extraintestinal manifestations of idiopathic inflammatory bowel disease.
Danzi JT
Arch Intern Med; 1988 Feb; 148(2):297-302. PubMed ID: 3277559
[TBL] [Abstract][Full Text] [Related]
9. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management.
Larsen S; Bendtzen K; Nielsen OH
Ann Med; 2010 Mar; 42(2):97-114. PubMed ID: 20166813
[TBL] [Abstract][Full Text] [Related]
10. [Extraintestinal manifestations of inflammatory bowel diseases and their management].
Garamszegi M
Orv Hetil; 2011 Apr; 152(17):663-71. PubMed ID: 21464024
[TBL] [Abstract][Full Text] [Related]
11. Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis.
Greuter T; Vavricka SR
Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):307-317. PubMed ID: 30791773
[TBL] [Abstract][Full Text] [Related]
12. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
13. Hypergammaglobulinemia is a marker of extraintestinal manifestations in pediatric inflammatory bowel disease.
Matar M; Rinawi F; Shamir R; Assa A
Turk J Gastroenterol; 2017 Mar; 28(2):131-134. PubMed ID: 28124661
[TBL] [Abstract][Full Text] [Related]
14. Extra intestinal manifestations and complications in inflammatory bowel disease.
Marineaţă A; Rezuş E; Mihai C; Prelipcean CC
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):279-88. PubMed ID: 25076688
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease.
Andrisani G; Guidi L; Papa A; Armuzzi A
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):890-901. PubMed ID: 22953637
[TBL] [Abstract][Full Text] [Related]
16. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases.
Guillo L; Abreu M; Panaccione R; Sandborn WJ; Azevedo VF; Gensler L; Moghaddam B; Ahuja V; Ali SA; Allez M; Ananthakrishnan AN; Bhattacharya A; Dubinsky M; Griffiths A; Hart A; Korelitz B; Kotze PG; Koutroubakis IE; Lakatos PL; Lindsay JO; Magro F; Mantzaris GJ; Ng SC; O'Morain C; Panés J; Parigi T; Ran Z; Rogler G; Rubin DT; Sachar DB; Siegmund B; Steinwurz F; Tysk C; Vavricka S; Verstraete SG; Brezin AP; Haemel AK; Dignass A; Sands BE; Danese S; Peyrin-Biroulet L
Lancet Gastroenterol Hepatol; 2022 Mar; 7(3):254-261. PubMed ID: 35051383
[TBL] [Abstract][Full Text] [Related]
17. Extraintestinal complications of inflammatory bowel diseases.
Navrátil V; Cveková S; Slodička P; Aiglová K; Pipek B; Falt P
Vnitr Lek; 2021; 67(2):92-96. PubMed ID: 34074107
[TBL] [Abstract][Full Text] [Related]
18. Extraintestinal manifestations of inflammatory bowel disease.
Urlep D; Mamula P; Baldassano R
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):147-63. PubMed ID: 15990704
[TBL] [Abstract][Full Text] [Related]
19. Extraintestinal manifestations of Crohn's disease.
Juillerat P; Mottet C; Pittet V; Froehlich F; Felley C; Gonvers JJ; Vader JP; Michetti P
Digestion; 2007; 76(2):141-8. PubMed ID: 18239406
[TBL] [Abstract][Full Text] [Related]
20. Association between inflammatory bowel disease and primary sclerosing cholangitis: Insights from bibliometric analysis.
Tang Q; Li L; Li Y; Yin W; Zhong X
Medicine (Baltimore); 2024 May; 103(21):e38257. PubMed ID: 38788011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
